Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:45 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 0 0.000% | -2,583,821 (Position Closed) | View |
| 2023-02-14 4:14 pm Sale | 13G | CYBIN INC CYBN | ORBIMED CAPITAL LLC | 6,153,299 3.700% | -5,138,001 (-45.50%) | View |
| 2022-02-11 4:44 pm Purchase | 13G | SI-BONE Inc. SIBN | ORBIMED CAPITAL LLC | 2,305,300 6.900% | 2,305,300 (New Position) | View |
| 2022-02-11 4:32 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 2,583,821 8.700% | 90,712 (+3.64%) | View |
| 2022-02-11 4:20 pm Purchase | 13G | CYBIN INC CYBN | ORBIMED CAPITAL LLC | 11,291,300 7.000% | 11,291,300 (New Position) | View |
| 2022-02-11 4:15 pm Sale | 13G | APTOSE BIOSCIENCES INC NO APTO | ORBIMED CAPITAL LLC | 0 0.000% | -8,030,000 (Position Closed) | View |
| 2021-02-12 5:03 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 2,493,109 8.360% | 2,493,109 (New Position) | View |
| 2021-02-12 4:42 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | ORBIMED CAPITAL LLC | 8,030,000 9.040% | 8,030,000 (New Position) | View |
| 2020-02-14 12:00 pm Sale | 13G | Foamix Pharmaceuticals Ltd. FOMX | ORBIMED CAPITAL LLC | 2,577,982 4.170% | -2,617,348 (-50.38%) | View |